BIOMAT Database Logo BIOMAT Database Logo

Gynecomastia after low dose methotrexate therapy for rheumatoid arthritis. 1995

E Thomas, and J L Leroux, and F Blotman

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018501 Antirheumatic Agents Drugs that are used to treat RHEUMATOID ARTHRITIS. Anti-Rheumatic Agent,Anti-Rheumatic Drug,Antirheumatic Agent,Antirheumatic Disease-Modifying Second-Line Drug,Antirheumatic Drug,DMARD,Disease-Modifying Antirheumatic Drug,Disease-Modifying Antirheumatic Drugs,Anti-Rheumatic Agents,Anti-Rheumatic Agents, Non-Steroidal,Anti-Rheumatic Drugs,Antirheumatic Disease-Modifying Second-Line Drugs,Antirheumatic Drugs,Antirheumatic Drugs, Disease-Modifying,Disease-Modifying, Antirheumatic Second-Line Drugs,Agent, Anti-Rheumatic,Agent, Antirheumatic,Anti Rheumatic Agent,Anti Rheumatic Agents,Anti Rheumatic Agents, Non Steroidal,Anti Rheumatic Drug,Anti Rheumatic Drugs,Antirheumatic Disease Modifying Second Line Drug,Antirheumatic Disease Modifying Second Line Drugs,Antirheumatic Drug, Disease-Modifying,Antirheumatic Drugs, Disease Modifying,Disease Modifying Antirheumatic Drug,Disease Modifying Antirheumatic Drugs,Disease Modifying, Antirheumatic Second Line Drugs,Drug, Anti-Rheumatic,Drug, Antirheumatic,Drug, Disease-Modifying Antirheumatic,Non-Steroidal Anti-Rheumatic Agents

Related Publications

E Thomas, and J L Leroux, and F Blotman
Gynecomastia following low dose methotrexate therapy for rheumatoid arthritis.
April 1995, The Journal of rheumatology,
E Thomas, and J L Leroux, and F Blotman
Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis.
January 2007, Modern rheumatology,
E Thomas, and J L Leroux, and F Blotman
Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis.
October 1983, Arthritis and rheumatism,
E Thomas, and J L Leroux, and F Blotman
Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis ameliorated by folate supplement.
August 2010, Rheumatology international,
E Thomas, and J L Leroux, and F Blotman
[Low dose methotrexate therapy in rheumatoid arthritis].
June 1990, Ryumachi. [Rheumatism],
E Thomas, and J L Leroux, and F Blotman
Low dose pulse methotrexate therapy in rheumatoid arthritis.
January 1980, The Journal of rheumatology,
E Thomas, and J L Leroux, and F Blotman
Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis.
August 1987, Journal of the American Academy of Dermatology,
E Thomas, and J L Leroux, and F Blotman
Gynecomastia associated with low dose methotrexate therapy.
May 1983, Arthritis and rheumatism,
E Thomas, and J L Leroux, and F Blotman
Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis.
November 1985, Archives of internal medicine,
E Thomas, and J L Leroux, and F Blotman
Low dose methotrexate in rheumatoid arthritis.
January 1982, The Journal of rheumatology,
Copied contents to your clipboard!